Researchers at Brigham and Women’s Hospital, Harvard Medical School, have created a medical app called Aspirin Guide to help physicians decide which patients are candidates for the use of low dose aspirin in the primary prevention of atherosclerotic cardiovascular disease (ASCVD).

The medical app is based on an associated study that was published at the same time in JAMA Internal Medicine: Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease.   Aspirin Guide is mentioned specifically in the study and the authors recommend downloading the app to help implement the findings of the study.

This is the first time that a medical clinical decision app has been released concurrently with a major study — very exciting.

Aspirin Guide is a great example of how to make translational medicine come to life. Not only did researchers publish their studies in JAMA, but within their study they recommend physicians download the medical app so physicians can actually implement the results of the study in real time.

This enables physicians to practice evidence based medicine in real time and is a huge leap for digital medicine. In the future I suspect we will be seeing much more of this.

We will be posting a full review and demo of the Aspirin Guide medical app next week.

Aspirin guide app

Price: Free
iPhone, iPad Link
Android Link: Not available